WallStSmart

CME Group Inc (CME)vsNasdaq Inc (NDAQ)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

CME Group Inc generates 20% more annual revenue ($6.96B vs $5.78B). CME leads profitability with a 63.5% profit margin vs 36.1%. NDAQ appears more attractively valued with a PEG of 1.65. NDAQ earns a higher WallStSmart Score of 71/100 (B).

CME

Buy

63

out of 100

Grade: C+

Growth: 6.7Profit: 8.0Value: 4.3Quality: 4.5
Piotroski: 1/9Altman Z: -0.67

NDAQ

Strong Buy

71

out of 100

Grade: B

Growth: 7.3Profit: 8.5Value: 5.0Quality: 5.5
Piotroski: 7/9Altman Z: 1.35

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CME4 strengths · Avg: 9.5/10
Profit MarginProfitability
63.5%10/10

Keeps 64 of every $100 in revenue as profit

Operating MarginProfitability
65.8%10/10

Strong operational efficiency at 65.8%

Market CapQuality
$108.50B9/10

Large-cap with strong market position

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

NDAQ4 strengths · Avg: 9.3/10
Profit MarginProfitability
36.1%10/10

Keeps 36 of every $100 in revenue as profit

Operating MarginProfitability
50.6%10/10

Strong operational efficiency at 50.6%

Market CapQuality
$59.38B9/10

Large-cap with strong market position

EPS GrowthGrowth
31.5%8/10

Earnings expanding 31.5% YoY

Areas to Watch

CME3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
4.182/10

Expensive relative to growth rate

Altman Z-ScoreHealth
-0.672/10

Distress zone — elevated risk

NDAQ3 concerns · Avg: 3.3/10
PEG RatioValuation
1.654/10

Expensive relative to growth rate

P/E RatioValuation
29.0x4/10

Moderate valuation

Altman Z-ScoreHealth
1.352/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CME

The strongest argument for CME centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 63.5% and operating margin at 65.8%. Revenue growth of 13.0% demonstrates continued momentum.

Bull Case : NDAQ

The strongest argument for NDAQ centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 36.1% and operating margin at 50.6%. Revenue growth of 12.6% demonstrates continued momentum.

Bear Case : CME

The primary concerns for CME are Piotroski F-Score, PEG Ratio, Altman Z-Score.

Bear Case : NDAQ

The primary concerns for NDAQ are PEG Ratio, P/E Ratio, Altman Z-Score.

Key Dynamics to Monitor

NDAQ carries more volatility with a beta of 1.00 — expect wider price swings.

CME is growing revenue faster at 13.0% — sustainability is the question.

Monitor FINANCIAL DATA & STOCK EXCHANGES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NDAQ scores higher overall (71/100 vs 63/100), backed by strong 36.1% margins and 12.6% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CME Group Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.

Visit Website →

Nasdaq Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

Nasdaq, Inc. is an American multinational financial services corporation that owns and operates stock exchanges in the United States and Europe. It is headquartered in New York City.

Visit Website →

Want to dig deeper into these stocks?